| dc.contributor.advisor | 郭炳伸 | zh_TW |
| dc.contributor.author (Authors) | 劉德威 | zh_TW |
| dc.contributor.author (Authors) | Liu, Te-Wei | en_US |
| dc.creator (作者) | 劉德威 | zh_TW |
| dc.creator (作者) | Liu, Te-Wei | en_US |
| dc.date (日期) | 2021 | en_US |
| dc.date.accessioned | 1-Feb-2021 14:01:51 (UTC+8) | - |
| dc.date.available | 1-Feb-2021 14:01:51 (UTC+8) | - |
| dc.date.issued (上傳時間) | 1-Feb-2021 14:01:51 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0105932183 | en_US |
| dc.identifier.uri (URI) | http://nccur.lib.nccu.edu.tw/handle/140.119/133852 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 經營管理碩士學程(EMBA) | zh_TW |
| dc.description (描述) | 105932183 | zh_TW |
| dc.description.abstract (摘要) | 中樞神經系統疾病，例如脊髓損傷和腦中風，是常見造成患者失能和動作障礙的原因，而外骨骼復健機器人是神經損傷恢復最有效的治療方法之一。根據世界衛生組織的數據顯示，全世界每年有1,500萬新增中風患者和25-50萬新增脊髓損傷患者。因此，新興的外骨骼復健機器人行業具有巨大的增長潛力。外骨骼機器人是一種高科技智慧醫材，整合機械、電子、智慧控制、生物力學、與臨床醫學於一體。福寶科技作為華人第一支投入外骨骼機器人的技術研發團隊，公司的願景是為身障朋友擁有正常的社交生活做努力，研發有溫度的科技來重新鏈結這個世界。本論文藉由研究外骨骼仿生設備之產業分析與福寶新創之競爭力分析，透過有系統的梳理與分析，同時考慮 Outside-in 與 Inside-out 的完整掃描外部環境與內在組織能力，探討福寶新創之競爭策略。研究發現: 首先，福寶科技可以投入外骨骼機器人智慧關節模組研發、開發遠距(居家)復健解決方案與完善外骨骼仿生核心產品矩陣。其次，通過將機器學習與人工智慧相結合，幫助物理治療師解決行業困境，創造新的市場機會。接下來，確定客戶價值驅動因素與找出產品致勝關鍵，改善產品競爭劣勢，並創造產品差異化。最後，先以台灣作為驗證市場，再逐步推廣至有競爭優勢地區。根據作者在新事業發展多年的領導經驗，新創事業發展過程會是反覆修正策略的，透過本論文的研究，期許幫助新創公司福寶科技找到未來的競爭策略。 | zh_TW |
| dc.description.abstract (摘要) | Central nervous system diseases, such as spinal cord injury and stroke, are common causes of disability and movement disorders. One of the most effective treatments for nerve injury recovery involves the use of exoskeleton rehabilitation robots. According to data from the World Health Organization, there are 15 million new stroke patients and 25–50 million new spinal cord injury patients worldwide each year. Therefore, the emerging exoskeleton rehabilitation industry has substantial growth potential. A robotic exoskeleton is a high-tech intelligent medical device integrating machinery, electronics, intelligent control, biomechanics, and clinical medicine. FREE Bionics is the first Chinese R&D team to invest in exoskeleton robots. The company`s vision is to develop exoskeleton technology so that disabled individuals can have normal social lives and reconnect with the world. In this study, an industrial analysis of exoskeletons and a competitiveness analysis of FREE Bionics were conducted to develop a competitive strategy for the company. The research findings are as follows. First, FREE Bionics can invest in robot smart joint modules, develop telemedicine rehabilitation solutions, and improve the core product matrix of exoskeleton bionics. Second, machine learning, and artificial intelligence can be combined to help physiotherapists solve difficulties and create new market opportunities. Next, FREE Bionics should identify customer value drivers, address product competitive disadvantages, and create product differentiation. Finally, Taiwan should be selected as a verification market, after which the products can gradually be promoted to regions with competitive advantages. Based on the author’s leadership and experience in new business development, the strategies of new ventures will be revised repeatedly. From the research presented in this thesis, FREE Bionics will be able to develop a future competitive strategy. | en_US |
| dc.description.tableofcontents | 第一章 緒論 1第一節 研究動機 1第二節 研究問題 3第三節 研究方法 4第二章 外骨骼仿生設備產業分析 7第一節 台灣生技產業現況 7第二節 復健機器人是神經損傷恢復最有效療法之一 8第三節 外骨骼復健機器人行業未來潜力巨大 11第四節 外骨骼機器人的PEST分析 16第五節 外骨骼機器人的五力分析 36第六節 外骨骼機器人的機會與威脅總結 39第三章 福寶新創之競爭力分析 42第一節 福寶科技新創公司簡介 42第二節 福寶科技技術盤點分析 47第三節 福寶科技產業價值鏈分析 55第四節 福寶科技企業價值鏈分析 58第五節 福寶科技的優勢與劣勢總結 61第四章 福寶新創之競爭策略 63第一節 福寶科技的策略區塊分析 63第二節 商業機會分析 (S/O策略) 69第三節 轉型分析 (W/O策略) 77第四節 市場創造 (S/T策略) 82第五節 商業風險分析 (W/T策略) 85第五章 結論 88第一節 本論文探討深耕台灣，聚焦策略區塊 88第二節 放眼世界積極開拓國際市場是下一階段研究目標 92參考文獻 94 | zh_TW |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0105932183 | en_US |
| dc.subject (關鍵詞) | 外骨骼機器人 | zh_TW |
| dc.subject (關鍵詞) | 復健 | zh_TW |
| dc.subject (關鍵詞) | 智慧醫材 | zh_TW |
| dc.subject (關鍵詞) | robotic exoskeleton | en_US |
| dc.subject (關鍵詞) | rehabilitation | en_US |
| dc.subject (關鍵詞) | intelligent medical device | en_US |
| dc.title (題名) | 外骨骼仿生設備公司之競爭策略- 以福寶新創為例 | zh_TW |
| dc.title (題名) | Competitive Strategy in Exoskeleton Industry Sector- FREE Bionics Startup as an Example | en_US |
| dc.type (資料類型) | thesis | en_US |
| dc.relation.reference (參考文獻) | 書籍1.麥可．波特，(2004)。競爭策略。台北市：天下遠見出版。2.麥可．波特，(2010)。競爭優勢(上、下)。台北市：天下遠見出版。市場報告1.Transparency Market Research “Global Robotic Rehabilitation and Assistive Technologies Market”2.Exoskeleton Market Global Forecast to 2023 (MARKETSandMARKETS)3.Medical Robotics Transforming Healthcare – Price-Cost Benefit Assessment (MARKETSandMARKETS)學術期刊1.Risk management and regulations for lower limb medical exoskeletons: a review (Dove Press Journal: Medical Devices: Evidence and Research)2.Gorgey AS. Robotic exoskeletons: The current pros and cons. WJO, 2018;9:112-119.3.Contreras-Vidal JL, A Bhagat N, Brantley J, Cruz-Garza JG, He Y, Manley Q, Nakagome S, Nathan K, Tan SH, Zhu F, Pons JL. Powered exoskeletons for bipedal locomotion after spinal cord injury. J Neural Eng. 2016;13:031001.4.ReWalk de novo summary: https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN130034.pdf.網際網路1.90% 中風與危險因子有關，中風預防人人有責！│家天使居家照顧https://ghsha.com/articles/1562.勤業眾信《2019生技醫療產業展望》報告https://www2.deloitte.com/content/dam/Deloitte/tw/Documents/life-sciences-health-care/%E5%8B%A4%E6%A5%AD%E7%9C%BE%E4%BF%A1%E3%80%8A2019%E7%94%9F%E6%8A%80%E9%86%AB%E7%99%82%E7%94%A2%E6%A5%AD%E5%B1%95%E6%9C%9B%E3%80%8B%E5%A0%B1%E5%91%8A.pdf3.什麼是脊髓損傷? (桃園脊髓損傷潛能發展中心)https://www.scsrc.org.tw/art.php?no=314.脊髓損傷傷後概況 (桃園脊髓損傷潛能發展中心)https://www.scsrc.org.tw/art.php?no=395.107年國人死因統計結果https://www.mohw.gov.tw/cp-16-48057-1.html6.腦血管疾病https://www.hpa.gov.tw/Pages/List.aspx?nodeid=2137.中風預防人人有責! 90%的中風均與危險因子有關https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1137&pid=78618.新版歐盟醫療器材法規(MDR)對於臨床評估之審查要求 (簡廷翰)https://www.cde.org.tw/Content/Files/Knowledge/f0ef83db-8439-4671-a5db-6dfc9fe526b7.pdf9.各國醫療器材法規概況https://www.sipa.gov.tw/uploaddowndoc?flag=doc&file=/pubdata/news/201607221410140.pdf10.中国投资者与加州外骨骼公司的合资企业被勒令解散https://cn.wsj.com/articles/%E4%B8%AD%E5%9B%BD%E6%8A%95%E8%B5%84%E8%80%85%E4%B8%8E%E5%8A%A0%E5%B7%9E%E5%A4%96%E9%AA%A8%E9%AA%BC%E5%85%AC%E5%8F%B8%E7%9A%84%E5%90%88%E8%B5%84%E4%BC%81%E4%B8%9A%E8%A2%AB%E5%8B%92%E4%BB%A4%E8%A7%A3%E6%95%A3-1159002761011.生技產業大利多 擴大租稅獎勵範圍及年限https://home.kpmg/tw/zh/home/media/press-releases/2020/07/tw-biotechnology-industry-tax-discount-and-deadline.html12.全民健康保險會：「110年度健保總額協商結果」http://www.tsim.org.tw/board/348.files/348-10.html13.動作的專家 淪為「高級作業員」https://www.businesstoday.com.tw/article/category/80392/post/201811280007/%E5%8B%95%E4%BD%9C%E7%9A%84%E5%B0%88%E5%AE%B6%20%20%E6%B7%AA%E7%82%BA%E3%80%8C%E9%AB%98%E7%B4%9A%E4%BD%9C%E6%A5%AD%E5%93%A1%E3%80%8D14.Spinal Cord Injury Facts and Figures at a Glancehttps://www.nscisc.uab.edu/Public/Facts%20and%20Figures%202019%20-%20Final.pdf15.醫療器械產品如何獲得CE認證http://kjisc.blogspot.com/2013/10/ce.html16.淺談動力外骨骼發展(上) (尖端科技軍事雜誌社)https://www.dtmdatabase.com/News.aspx?id=73017.9種走路方式，揪出潛藏健康危機https://health.tvbs.com.tw/regimen/32224018.Hype Cycle for Emerging Technologies, 2018https://www.gartner.com/en/newsroom/press-releases/2018-08-20-gartner-identifies-five-emerging-technology-trends-that-will-blur-the-lines-between-human-and-machine19.Ford, Ekso team up for `bionic` auto workershttps://www.reuters.com/article/us-ford-ekso-workers-idUSKBN1D93B020.Ratnik: esta es la armadura de combate rusa para hacer `invencibles` a sus soldadoshttps://www.elconfidencial.com/tecnologia/2018-08-28/ratnik-armadura-supersoldado-rusia-rostec_1608984/ | zh_TW |
| dc.identifier.doi (DOI) | 10.6814/NCCU202100089 | en_US |
